Cargando…

N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

BACKGROUND: Epidemiological and clinical evidence suggests that high-dose intake of omega 3 fatty acids (n-3 FA) have a favorable role in altering serum triglycerides (TG) and non-high density lipoprotein cholesterol (non-HDL-C) when combined with statins in hyperlipidemic patients. Their efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dogay Us, Gediz, Mushtaq, Sohail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434850/ https://www.ncbi.nlm.nih.gov/pubmed/36050695 http://dx.doi.org/10.1186/s12944-022-01686-y

Ejemplares similares

Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
por: Krähenbühl, Stephan, et al.
Publicado: (2016)

Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
por: Otrante, Alyann, et al.
Publicado: (2023)

Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial
por: Dohlmann, Tine L., et al.
Publicado: (2022)

Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Young Kim, Sun, et al.
Publicado: (2022)

Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker
por: Hwang, Ha Won, et al.
Publicado: (2020)

Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL
por: Vekic, Jelena, et al.
Publicado: (2022)

Small Dense LDL Tied to Diabetic Retinopathy-Similarity to Atherosclerosis
por: Hirano, Tsutomu
Publicado: (2022)

A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
por: Shanes, Jeffrey G.
Publicado: (2011)

Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?
por: Baruch, Lawrence, et al.
Publicado: (2013)

Daily Nutritional Dose Supplementation with Antioxidant Nutrients and Phytochemicals Improves DNA and LDL Stability: A Double-Blind, Randomized, and Placebo-Controlled Trial
por: Kim, You Jin, et al.
Publicado: (2013)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review
por: Talebi, Sepide, et al.
Publicado: (2020)

The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy
por: Chen, Yanmin, et al.
Publicado: (2017)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

Triglyceride and Small Dense LDL-Cholesterol in Patients with Acute Coronary Syndrome
por: Hori, Masakazu, et al.
Publicado: (2021)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
por: Suh, Sunghwan, et al.
Publicado: (2011)

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
por: Hirano, Tsutomu, et al.
Publicado: (2022)

Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
por: Derosa, Giuseppe, et al.
Publicado: (2019)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Prevalence of plasma small dense LDL is increased in obesity in a Thai population
por: Kulanuwat, Sirikul, et al.
Publicado: (2015)

Influence of Metabolic Syndrome on Small, Dense LDL, and Subclinical Atherosclerosis in Older Subjects
por: Yoshino, Hiroshi, et al.
Publicado: (2023)

Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children
por: Grabarczyk, Małgorzata, et al.
Publicado: (2022)

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Rahimlou, Mehran, et al.
Publicado: (2016)

Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy
por: Ciric, Milica Zrnic, et al.
Publicado: (2021)

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014)

Evaluation of LDL goal achievement in statin consumption, south east of Iran
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study
por: Kolahi, Sousan, et al.
Publicado: (2015)

Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with ‘Normal’ LDL-C Levels
por: Superko, Harold, et al.
Publicado: (2022)

Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you need
por: Bitzur, Rafael
Publicado: (2011)

Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jun, Ji Eun, et al.
Publicado: (2020)

Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
por: Katzmann, Julius L., et al.
Publicado: (2020)

Statin Induced Regression of Cardiomyopathy Trial: A Randomized, Placebo-controlled Double-blind Trial
por: Hersi, Ahmad, et al.
Publicado: (2016)

Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation
por: Fan, Jiahua, et al.
Publicado: (2019)

Prognostic Implication of Small Dense LDL-Cholesterol Levels following Acute Coronary Syndrome
por: Imamura, Teruhiko, et al.
Publicado: (2023)

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
por: Toth, Peter P., et al.
Publicado: (2016)

Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial
por: Matli, Kamal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ui3rc4btp6jjeqv8ofohk209m6